Interesting that this is a timeline I dont seem to have heard before re: September, and the hospitals involved
TESS LIVINGSTONE THE AUSTRALIAN MAY 29, 2014
Taking fight to cancer
A PROMISING therapy against pancreatic cancer will trialled in Australia from September.
Patients will have a medical ?device inserted directly into their ?tumours, where it will produce local radiation designed to combat the cancer.
Initial trials of the treatment, developed by Australian biomedical company OncoSil Medical, were encouraging. Of 17 patients injected with the device in Singapore and Britain, almost half were alive without progression of the disease after 18 months and the median survival time was greater than 10 months, with a big ?reduction in pain.
OncoSil Medical chief executive Neil Frazer said such results were “extremely positive’’.
Pancreatic cancer is one of the most deadly forms of cancer, with little or no improvement in survival rates over 40 years.
Only 5 to 6 per cent of patients are alive five years after diagnosis. More than 40 Australians die of the disease every week.
“OncoSil is administered in a single dose under light anaesthesia,’’ Dr Fraser said.
Pancreatic cancer patients will be treated at the Royal North Shore, St Vincent’s and Liverpool and Bankstown hospitals in ?Sydney and the Monash Medical Centre in Melbourne, and at ?several centres in the US and ?Europe.
- Forums
- ASX - By Stock
- article in the australian
OSL
oncosil medical ltd
Add to My Watchlist
5.69%
!
$1.16

Interesting that this is a timeline I dont seem to have heard...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 412 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
1 | 2500 | 1.030 |
1 | 550 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 412 | 1 |
1.200 | 8677 | 1 |
1.245 | 2418 | 1 |
1.250 | 46027 | 1 |
1.300 | 1500 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online